Fortress Biotech, Inc. (FBIO, FBIOP)
CIK 1429260 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fortress Biotech, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 1, 2026 | SCHEDULE 13G | 0001104659-26-104386 |
| Aug 13, 2026 | 8-K | 0001104659-26-095931 |
| Aug 13, 2026 | 10-Q | 0001104659-26-095964 |
| Jun 24, 2026 | 4 | 0001930732-26-000003 |
| Jun 23, 2026 | 8-K | 0001104659-26-076811 |
| May 15, 2026 | SCHEDULE 13G/A | 0000919574-26-003180 |
| May 14, 2026 | 10-Q | 0001104659-26-061233 |
| May 14, 2026 | 8-K | 0001104659-26-061208 |
| Apr 28, 2026 | DEFA14A | 0001104659-26-050366 |
| Apr 28, 2026 | DEF 14A | 0001104659-26-050358 |
| Apr 1, 2026 | 4 | 0001930732-26-000002 |
| Mar 31, 2026 | 10-K | 0001104659-26-037874 |
| Mar 31, 2026 | 8-K | 0001104659-26-037749 |
| Mar 30, 2026 | 8-K | 0001104659-26-036818 |
| Mar 20, 2026 | SCHEDULE 13D/A | 0001104659-26-032728 |
| Mar 20, 2026 | 4 | 0001038977-26-000002 |
| Mar 20, 2026 | 4 | 0000941841-26-000002 |
| Feb 23, 2026 | 8-K | 0001104659-26-018371 |
| Jan 13, 2026 | 8-K | 0001104659-26-003121 |
| Jan 6, 2026 | 4 | 0001429260-26-000004 |
| Jan 6, 2026 | SCHEDULE 13D/A | 0001104659-26-001305 |
| Jan 5, 2026 | 4 | 0001772558-26-000002 |
| Jan 5, 2026 | 4 | 0001647971-26-000002 |
| Jan 5, 2026 | SCHEDULE 13D/A | 0001104659-26-000690 |
| Jan 5, 2026 | 4 | 0001172659-26-000002 |